Michael Esman Chernew

Michael Esman Chernew's AcademicInfluence.com Rankings

Economics

#3208

World Rank

#3636

Historical Rank

economics Degrees

Download Badge

Economics

Michael Esman Chernew's Degrees

PhD Economics Stanford University

Why Is Michael Esman Chernew Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael Esman Chernew's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Willingness to Pay for a Quality-adjusted Life Year (2000) (902)
What is the price of life and why doesn't it increase at the rate of inflation? (2003) (582)
National estimates of the quantity and cost of informal caregiving for the elderly with dementia (2001) (430)
Measuring low-value care in Medicare. (2014) (377)
Using propensity scores in difference-in-differences models to estimate the effects of a policy change (2014) (336)
Impact of decreasing copayments on medication adherence within a disease management environment. (2008) (332)
Early Performance of Accountable Care Organizations in Medicare. (2016) (326)
Value-based insurance design. (2007) (237)
The 'Alternative Quality Contract,' based on a global budget, lowered medical spending and improved quality. (2012) (235)
Estimating the cost of informal caregiving for elderly patients with cancer. (2001) (217)
Performance differences in year 1 of pioneer accountable care organizations. (2015) (211)
A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. (2001) (207)
Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease (1995) (204)
Health care spending and quality in year 1 of the alternative quality contract. (2011) (203)
Changes in health care spending and quality 4 years into global payment. (2014) (203)
A systemic approach to containing health care spending. (2012) (193)
Quality and Consumer Decision Making in the Market for Health Insurance and Health Care Services (2009) (181)
The impact of health plan report cards on managed care enrollment. (2002) (161)
Private-payer innovation in Massachusetts: the 'alternative quality contract'. (2011) (159)
The demand for health insurance coverage by low-income workers: can reduced premiums achieve full coverage? (1997) (154)
Changes in patients' experiences in Medicare Accountable Care Organizations. (2014) (153)
Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications (2008) (151)
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis (2001) (143)
Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care (2008) (140)
Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract. (2013) (136)
Out-of-pocket health-care expenditures among older Americans with cancer. (2004) (135)
Changes in Postacute Care in the Medicare Shared Savings Program (2017) (134)
Health Care Spending Growth (2011) (133)
Medicare Spending after 3 Years of the Medicare Shared Savings Program (2018) (133)
Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices. (2015) (132)
Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program. (2015) (127)
THE COMMONWEALTH FUND Commission on a High Performance Health System (2005) (124)
Consumer health plan choice: current knowledge and future directions. (1997) (123)
Increased spending on health care: how much can the United States afford? (2003) (122)
Health plan report cards and insurance choice. (1998) (119)
Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries. (2007) (109)
Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017 (2019) (109)
Endoscopic versus Open Carpal Tunnel Release: A Cost‐Effectiveness Analysis (1998) (106)
Delivery system integration and health care spending and quality for Medicare beneficiaries. (2013) (105)
Geographic correlation between large-firm commercial spending and Medicare spending. (2010) (103)
Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. (1996) (101)
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. (1999) (101)
Managed Care, Medical Technology, and Health Care Cost Growth: A Review of the Evidence (1998) (100)
The Spillover Effects of Medicare Managed Care: Medicare Advantage and Hospital Utilization (2013) (98)
Evidence that value-based insurance can be effective. (2010) (97)
Association Between Availability of a Price Transparency Tool and Outpatient Spending. (2016) (95)
Increasing Health Insurance Costs and the Decline in Health Insurance Coverage (2005) (93)
The Explosion in Paid Home Health Care in the 1990s: Who Received the Additional Services? (2001) (90)
Increased spending on health care: long-term implications for the nation. (2009) (88)
Informal caregiving for diabetes and diabetic complications among elderly americans. (2002) (85)
Outpatient care patterns and organizational accountability in Medicare. (2014) (85)
Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data. (2013) (84)
Managed Care and Medical Expenditures of Medicare Beneficiaries (2008) (80)
What does the RAND Health Insurance Experiment tell us about the impact of patient cost sharing on health outcomes? (2008) (77)
The specter of financial armageddon--health care and federal debt in the United States. (2010) (77)
Insurance type and choice of hospital for coronary artery bypass graft surgery. (1998) (75)
Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. (2006) (72)
The impact of Medicare Part D on hospitalization rates. (2011) (71)
Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. (1996) (65)
The Impact of Medicare Part D on Medication Adherence Among Older Adults Enrolled in Medicare-Advantage Products (2010) (64)
Medicare ACO Program Savings Not Tied To Preventable Hospitalizations Or Concentrated Among High-Risk Patients. (2017) (63)
Medicaid incentive programs to encourage healthy behavior show mixed results to date and should be studied and improved. (2013) (63)
Disability and health care spending among medicare beneficiaries. (2005) (62)
Ownership, competition, and the adoption of new technologies and cost-saving practices in a fixed-price environment. (2000) (62)
Competitive bidding in Medicare Advantage: effect of benchmark changes on plan bids. (2013) (61)
Bending The Spending Curve By Altering Care Delivery Patterns: The Role Of Care Management Within A Pioneer ACO. (2017) (57)
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. (2012) (57)
Standards for Measures Used for Public Reporting of Efficiency in Health Care: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation (2008) (57)
Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees. (2017) (57)
The impact of non-IPA HMOs on the number of hospitals and hospital capacity. (1995) (56)
Chronic Illness, Treatment Choice and Workforce Participation (2004) (56)
Optimal health insurance: the case of observable, severe illness. (2000) (55)
Medical group responses to global payment: early lessons from the 'Alternative Quality Contract' in Massachusetts. (2011) (54)
Physician Work Hours and the Gender Pay Gap - Evidence from Primary Care. (2020) (53)
Little Evidence Exists To Support The Expectation That Providers Would Consolidate To Enter New Payment Models. (2017) (52)
Ensuring the fiscal sustainability of health care reform. (2010) (52)
Effect of Medicare Home Health Care Payment on Informal Care (2009) (52)
Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. (2006) (52)
Does competition improve health care quality? (2008) (52)
Changes in Health Care Use Associated With the Introduction of Hospital Global Budgets in Maryland (2018) (51)
Applying value-based insurance design to low-value health services. (2010) (50)
The sources of the SGR "hole". (2012) (48)
Health Care Spending, Utilization, and Quality 8 Years into Global Payment. (2019) (48)
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation. (2008) (48)
Oregon's Medicaid Transformation: An Innovative Approach To Holding A Health System Accountable For Spending Growth. (2014) (47)
Managed care and medical technology: implications for cost growth. (1997) (46)
Understanding the Improvement in Disability Free Life Expectancy in the U.S. Elderly Population (2016) (46)
Would having more primary care doctors cut health spending growth? (2009) (45)
Approval times for new drugs: does the source of funding for FDA staff matter? (2003) (45)
Learning and the Value of Information: The Case of Health Plan Report Cards (2002) (44)
The slowdown in health care spending in 2009-11 reflected factors other than the weak economy and thus may persist. (2013) (44)
Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. (1996) (43)
Increasing health insurance costs and the decline in insurance coverage. (2005) (43)
HEDIS Measures and Managed Care Enrollment (1999) (41)
Titrating Versus Targeting Home Care Services to Frail Elderly Clients (2003) (41)
Value-based cost sharing in the United States and elsewhere can increase patients' use of high-value goods and services. (2013) (41)
Low‐Value Service Use in Provider Organizations (2018) (40)
Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices. (2017) (40)
Two-Year Impact of the Alternative Quality Contract on Pediatric Health Care Quality and Spending (2014) (40)
Oregon's Medicaid Reform And Transition To Global Budgets Were Associated With Reductions In Expenditures. (2017) (40)
HMO Participation in Medicare+Choice (2005) (40)
Value-Based Insurance Design: A “Clinically Sensitive, Fiscally Responsible” Approach to Mitigate The Adverse Clinical Effects of High-Deductible Consumer-Directed Health Plans (2007) (39)
Preference diversity and the breadth of employee health insurance options. (2001) (39)
The Effect of a Large Regional Health Plan’s Value-based Insurance Design Program on Statin Use (2012) (38)
A new medicare end-of-life benefit for nursing home residents. (2010) (38)
Health plan report cards: exploring differences in plan ratings. (1998) (37)
Bending the curve: effective steps to address long-term healthcare spending growth. (2009) (37)
Competitive bidding in Medicare: who benefits from competition? (2012) (36)
A hospital system's wellness program linked to health plan enrollment cut hospitalizations but not overall costs. (2013) (36)
Quality and employers' choice of health plans. (2004) (36)
Barriers to constraining health care cost growth. (2004) (35)
New Anticancer Drugs Associated With Large Increases In Costs And Life Expectancy. (2016) (35)
Changes In Hospital Utilization Three Years Into Maryland's Global Budget Program For Rural Hospitals. (2018) (35)
Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis. (2002) (35)
Competition and Health Plan Performance: Evidence from Health Maintenance Organization Insurance Markets (2005) (33)
Competition in Health Insurance Markets: Limitations of Current Measures for Policy Analysis (2006) (32)
Insurer market structure and variation in commercial health care spending. (2014) (30)
Effects of Episode-Based Payment on Health Care Spending and Utilization: Evidence from Perinatal Care in Arkansas (2017) (29)
Value-based insurance design: embracing value over cost alone. (2009) (29)
Personalized Targeted Mailing Increases Mammography Among Long-Term Noncompliant Medicare Beneficiaries: A Randomized Trial (2003) (28)
Medicare Fee Cuts and Cardiologist-Hospital Integration. (2015) (28)
Promise and Reality of Price Transparency. (2018) (28)
Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. (1997) (27)
Global Budgets and Technology-Intensive Medical Services. (2013) (27)
Post-acute care and ACOs - who will be accountable? (2013) (27)
The Impact of a Tiered Network on Hospital Choice. (2015) (26)
Lower- Versus Higher-Income Populations In The Alternative Quality Contract: Improved Quality And Similar Spending. (2017) (26)
Insurance Transitions and Changes in Physician and Emergency Department Utilization: An Observational Study (2017) (25)
The Effect of Medicare Advantage on Hospital Admissions and Mortality (2013) (25)
Beyond managed long-term care: paying for home care based on risk of adverse outcomes. (2001) (25)
Medicare Advantage Ratings And Voluntary Disenrollment Among Patients With End-Stage Renal Disease. (2018) (25)
Health and Economic Activity Over the Lifecycle: Literature Review (2018) (25)
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S (2020) (25)
The Early Impact Of The 'Alternative Quality Contract' On Mental Health Service Use And Spending In Massachusetts. (2015) (25)
Screening Mammography for Free: Impact of Eliminating Cost Sharing on Cancer Screening Rates (2017) (25)
Bundled payment systems: can they be more successful this time. (2010) (24)
Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? (2005) (23)
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy (2002) (23)
Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract (2017) (23)
A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial (2009) (22)
Premium Transparency in the Medicare Advantage Market: Implications for Premiums, Benefits, and Efficiency (2014) (22)
Overlap in HMO physician networks. (2004) (21)
Price elasticity and medication use: cost sharing across multiple clinical conditions. (2014) (21)
Enrollment In A Health Plan With A Tiered Provider Network Decreased Medical Spending By 5 Percent. (2017) (21)
Case management: effects of improved risk and value information. (2003) (21)
Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis (1998) (20)
Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015. (2020) (20)
The impact of managed care on the existence of equilibrium in health insurance markets. (1999) (20)
Are Health Care Services Shoppable? Evidence from the Consumption of Lower-Limb MRI Scans (2018) (20)
Decomposing pharmaceutical cost growth in different types of health plans. (2001) (20)
Rising out-of-pocket costs in disease management programs. (2006) (20)
Substantial Physician Turnover And Beneficiary 'Churn' In A Large Medicare Pioneer ACO. (2017) (20)
Value based insurance design: maintaining a focus on health in an era of cost containment. (2009) (20)
Market and Plan Characteristics Related to HMO Quality and Improvement (2006) (20)
Pharmaceutical cost growth under capitation: a case study. (2000) (19)
Engaging Health Care Users: A Framework for Healthy Individuals and Communities (2013) (19)
Early Impact Of CareFirst's Patient-Centered Medical Home With Strong Financial Incentives. (2017) (19)
Potential consequences of reforming Medicare into a competitive bidding system. (2012) (18)
Design and implementation of bundled payment systems for cancer care and radiation therapy. (2014) (18)
PATIENT, PHYSICIAN, AND PAYER PERCEPTIONS AND MISPERCEPTIONS OF WILLINGNESS TO PAY FOR DIAGNOSTIC CERTAINTY (2000) (18)
Transforming Medicare's Payment Systems: Progress Shaped By The ACA. (2020) (18)
Beneficial Moral Hazard and the Theory of the Second Best (2009) (18)
Bending the curve through health reform implementation. (2010) (17)
Value-based insurance design: benefits beyond cost and utilization. (2015) (17)
Managed care and open-heart surgery facilities in California. (1996) (17)
Managed Care for Elderly People: A Compendium of Findings (1998) (17)
The economics of financing Medicare. (2011) (16)
Unintended consequences of eliminating medicare payments for consultations. (2013) (16)
Heterogeneity of Risk in a Managed Home Health Care Population (2001) (16)
Patient Population Loss At A Large Pioneer Accountable Care Organization And Implications For Refining The Program. (2016) (16)
How much savings can we wring from Medicare? (2011) (15)
Value and increased cost sharing in the American health care system. (2008) (15)
Who Uses a Price Transparency Tool? Implications for Increasing Consumer Engagement (2017) (15)
Cost of contraceptive methods to privately insured women in the United States. (2013) (15)
Wide State-Level Variation In Commercial Health Care Prices Suggests Uneven Impact Of Price Regulation. (2020) (15)
The Importance of Relative Prices in Health Care Spending. (2018) (15)
General Equilibrium and Marketability in the Health Care Industry (2001) (15)
The impact of the Affordable Care Act on Medicare Advantage plan availability and enrollment. (2012) (15)
THE PHYSICIAN LABOR MARKET IN A MANAGED CARE‐DOMINATED ENVIRONMENT (1999) (15)
CMS Payments Necessary to Support HMO Participation in Medicare Managed Care (2002) (15)
Crowd-out in the State Children's Health Insurance Program (SCHIP): incidence, enrollee characteristics and experiences, and potential impact on New York's SCHIP. (2008) (15)
Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes Treatment (2019) (14)
Why physicians should like bundled payment. (2011) (14)
Precision Benefit Design-Using "Smarter" Deductibles to Better Engage Consumers and Mitigate Cost-Related Nonadherence. (2017) (14)
Geographic Variation in Quality of Care for Commercially Insured Patients (2014) (13)
Savings or Selection? Initial Spending Reductions in the Medicare Shared Savings Program and Considerations for Reform. (2020) (13)
Measuring Prices in Health Care Markets Using Commercial Claims Data. (2015) (13)
Charity Care, Risk Pooling, and the Decline in Private Health Insurance. (2005) (13)
Compensating wage differentials and the impact of health insurance in the public sector on wages and hours. (2014) (13)
Medigap premiums and Medicare HMO enrollment. (2002) (13)
Improving Benefit Design to Promote Effective, Efficient, and Affordable Care. (2016) (13)
Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. (2002) (13)
Persistence of HMO performance measures. (2008) (12)
Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis. (1996) (12)
Optimal Managed Competition Subsidies (2019) (12)
Modeling Health Care Spending Growth of Older Adults (2018) (12)
Social Risk Adjustment of Quality Measures for Diabetes and Cardiovascular Disease in a Commercially Insured US Population (2019) (12)
Real-world impact of comparative effectiveness research findings on clinical practice. (2014) (12)
Nearly One-Third Of Enrollees In California's Individual Market Missed Opportunities To Receive Financial Assistance. (2017) (12)
The Relationship between Commercial Health Care Prices and Medicare Spending and Utilization. (2015) (12)
Health Care Cost Growth (2011) (12)
Spillovers in Health Care Markets : Implications for Current Law Projections (2010) (12)
Regulatory neutrality is essential to establishing a level playing field for accountable care organizations. (2013) (11)
Effects of Global Payment and Accountable Care on Tobacco Cessation Service Use: An Observational Study (2016) (11)
Trends in Patient Cost Sharing for Clinical Services Used as Quality Indicators (2010) (11)
Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes. (2013) (11)
How Accountable Care Organizations Responded to Pediatric Incentives in the Alternative Quality Contract. (2016) (10)
Health Care Spending Growth: Can We Avoid Fiscal Armageddon? (2010) (10)
"Fiscally responsible, clinically sensitive" cost sharing: contain costs while preserving quality. (2007) (10)
High-Risk Medication Use by Nursing Home Residents Before and After Hospitalization (2014) (10)
The cost-effectiveness of early noninvasive ventilation for ALS patients (2005) (10)
The Impact of Global Budgets on Pharmaceutical Spending and Utilization (2014) (10)
MODELING THE CAUSES AND CONSEQUENCES OF LACK OF HEALTH INSURANCE COVERAGE : GAPS IN THE LITERATURE (2002) (10)
Diffusion of Bevacizumab Across Oncology Practices: An Observational Study (2018) (9)
The effect of bundled payment on emergency department use: alternative quality contract effects after year one. (2013) (9)
Physician Practice Interruptions in the Treatment of Medicare Patients During the COVID-19 Pandemic. (2021) (9)
Clinically sensitive cost-sharing for prescription drugs: thinking beyond the silos. (2009) (9)
Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders (2017) (9)
CT Angiography is Cost‐Effective for Confirmation of Internal Carotid Artery Occlusions (2008) (9)
Targeted Supplemental Data Collection - Addressing the Quality-Measurement Conundrum. (2018) (9)
Administrative Expenses in the US Health Care System: Why So High? (2021) (9)
Cost Sharing and HEDIS Performance (2008) (9)
Physician agency, consumerism, and the consumption of lower-limb MRI scans. (2021) (9)
Physician Organization and the Role of Workforce Turnover (2020) (8)
Changes In End-Of-Life Care In The Medicare Shared Savings Program. (2018) (8)
Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease. (1996) (8)
Alternative Alternative Payment Models. (2017) (8)
Potential Effects Of Eliminating The Individual Mandate Penalty In California. (2019) (8)
Prices for physician services in Medicare Advantage versus traditional Medicare. (2018) (8)
Worker preferences, sorting and aggregate patterns of health insurance coverage (2007) (8)
HMO Use of Diagnostic Tests: A Review of the Evidence (1995) (8)
Options for Assessing PPO Quality: Accreditation and Profiling as Accountability Strategies (2001) (8)
Managed Care and Performance Measurement (2000) (8)
Best of Both Worlds Uniting Universal Coverage and Personal Choice in Health Care (2013) (7)
Association Between Clinical Practice Group Adherence to Quality Measures and Adverse Outcomes Among Adult Patients With Diabetes (2019) (7)
Drug plan design incentives among Medicare prescription drug plans. (2014) (7)
Regulation of Health Care Prices: The Case for Backstop Price Caps in Commercial Health Care Markets. (2021) (7)
Health Insurance and Labor Markets: Concepts, Open Questions, and Data Needs (2007) (7)
Refining the ACO Program : Issues and Options (2015) (7)
Medicare Part D Plan Generosity and Medication Use Among Dual-eligible Nursing Home Residents (2013) (7)
Paying Patients To Switch: Impact Of A Rewards Program On Choice Of Providers, Prices, And Utilization. (2019) (7)
Willingness to pay for diagnostic certainty (1999) (7)
Willingness to pay for diagnostic certainty: comparing patients, physicians, and managed care executives. (1999) (7)
Performance in Year 1 of Pioneer Accountable Care Organizations. (2015) (7)
A Path Forward for Alternative Payment: Build a Portfolio Not a Garden. (2021) (6)
Supplemental coverage associated with more rapid spending growth for Medicare beneficiaries. (2013) (6)
Spending Reductions in the Medicare Shared Savings Program: Selection or Savings? (2019) (6)
Getting More Savings from ACOs - Can the Pace Be Pushed? (2019) (6)
Commentary on the spread of new payment models. (2013) (6)
Additional reductions in Medicare spending growth will likely require shifting costs to beneficiaries. (2013) (6)
Insurers' Competitive Strategy and Enrollment in Newly Offered Preferred Provider Organizations (PPOs) (2007) (6)
Consumer response to quality information. (1998) (6)
National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance (2018) (5)
Reforming payment for health care services: comment on "physicians' opinions about reforming reimbursement". (2010) (5)
Multimodality cancer care and implications for episode-based payments in cancer. (2019) (5)
Modeling the Health and Medical Care Spending of the Future Elderly (2008) (5)
Do Determinants of Medicare Supplemental Coverage Choice Vary by Income? (2006) (5)
The relationship between health plan performance measures and physician network overlap: implications for measuring plan quality. (2010) (5)
What are the potential savings from steering patients to lower-priced providers? a static analysis. (2019) (5)
Worker demand for health insurance in the non-group market: a note on the calculation of welfare loss. (1997) (5)
Spending variation among ACOs in the Medicare Shared Savings Program. (2020) (4)
Public Payment Rates For Hospitals And The Potential For Consolidation-Induced Cost Shifting. (2021) (4)
The 'graying' of group health insurance. (2006) (4)
Comparison of Approaches for Aggregating Quality Measures in Population‐based Payment Models (2018) (4)
State-level impacts of Medicare Part D. (2011) (4)
Understanding the Behavioral Response to Medical Innovation (1996) (4)
Regional Variation in Medication Adherence (2011) (4)
Assessment of Patient Attribution to Care From Medical Oncologists, Surgeons, or Radiation Oncologists After Newly Diagnosed Cancer (2021) (4)
The Role of Market Forces in U.S. Health Care. (2020) (4)
Impact of NSAID choice and patient symptoms on the cost-effectiveness of strategies to prevent NSAID gastropathy (1998) (4)
Treatment and cost implications of pertuzumab. (2012) (4)
Measurement Systems : A Framework for Next Generation Measurement of Quality in Healthcare (2019) (4)
Maryland's Hospital Global Budget Program. (2018) (3)
Paying patients to use lower-priced providers. (2021) (3)
The Arkansas Payment Improvement Initiative: Early Perceptions of Multi-Payer Reform in a Fragmented Provider Landscape (2015) (3)
Regulating Hospital Prices Based On Market Concentration Is Likely To Leave High-Price Hospitals Unaffected. (2021) (3)
Controlling the Cost of Medicaid. (2017) (3)
Effect of Part D Coverage Restrictions for Antidepressants, Antipsychotics, and Cholinesterase Inhibitors on Related Nursing Home Resident Outcomes (2014) (3)
Slowing Medicare spending growth: reaching for common ground. (2012) (3)
Private-Payer Innovation In Massachusetts : The (2011) (3)
Quality and Employers&Apos; Choice of Health Plan (2003) (3)
Cost-effectiveness of step-up vs. Step-down therapy for symptomatic gerd: An international perspective (2000) (2)
Understanding the Improvement in Disability-Free Life Expectancy in the U.S. Elderly Population (2016) (2)
Soft Consolidation In Medicare ACOs: Potential For Higher Prices Without Mergers Or Acquisitions. (2021) (2)
Options for Assessing PPO Quality: Accreditation and Profiling as Accountability Strategies (2001) (2)
Hierarchical Payment Models-A Path for Coordinating Population- and Episode-Based Payment Models. (2022) (2)
Adverse Selection into and within the Individual Health Insurance Market in California in 2014 (2018) (2)
Impact of an Episode-Based Payment Initiative by Commercial Payers in Arkansas on Procedure Volume: an Observational Study (2019) (2)
Coding-Driven Changes In Measured Risk In Accountable Care Organizations. (2021) (2)
The Value of Patent Expiration (2012) (2)
Disparities in payment across sites encourage consolidation. (2021) (2)
Research and reform: toward a high-value health system. (2009) (2)
Disability And Health Care Spending Among Medicare (2005) (2)
The challenges ahead for accountable care organizations (ACOs). (2011) (2)
Confronting hysteria: a reply to Fairman and Curtiss. (2008) (2)
Value-Based Insurance Design in the Medicare Prescription Drug Benefit: An Analysis of Policy Options (2009) (2)
Crowd-out in the State Children's Health Insurance Program (SCHIP): Incidence, enrollee characteristics and experiences, and potential impact on New York's SCHIP (Health Services Research (2008) 43, 3, 2, (419-434)) (2008) (2)
The 'Graying' of Group Health Insurance Coverage (2006) (1)
Disability and Spending Growth (2009) (1)
Comparative effectiveness research and formulary placement: the case of diabetes. (2013) (1)
Predictors of Hedis Performance and Improvement (2003) (1)
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the U.S.: Evidence from Medicines Sold in Retail Pharmacies. (2022) (1)
Organization and Performance of US Health Systems. (2023) (1)
Standards for Measures Used for Public Reporting of Efﬁciency in Health Care (2008) (1)
Do Commercial ACOs Save Money? Interpreting Diverse Evidence. (2019) (1)
Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty. (2023) (1)
Advocacy and Remedies for Healthcare Disparities (2004) (1)
The economics of resistant pathogens and antibiotic innovation. (2014) (1)
Cost-Sharing and Productivity (2012) (1)
Comments on Enthoven’s “The U.S. Experience with Managed Care and Managed Competition” (2005) (1)
ISQUA16-2413THE IMPACT OF NEW PAYMENT MODELS ON CARE DELIVERY: REDUCTIONS IN EMERGENCY CARE USE AMONG BENEFICIARIES IN A MEDICARE PIONEER ACO (2016) (1)
C11. Clinical and economic effects of Helicobacter pylori screening to prevent gastric cancer (1996) (1)
The impact of the adoption of gag laws on trust in the patient-physician relationship. (2007) (1)
PCN7: FAMILY CAREGIVING COSTS FOR THE ELDERLY WITH CANCER: ESTIMATES FROM A REPRESENTATIVE SAMPLE OF THE UNITED STATES (2000) (1)
The Value of New Anticancer Drugs (2016) (1)
Commentary by Hirth, Chernew, and Weissert (2005) (1)
Who Will Succeed with New Payment Models? Part 2 (2017) (1)
Cost sharing and branded antidepressant initiation among patients treated with generics. (2018) (1)
The Effect of Medicare Home Health Care Payment on Informal Care Use (2007) (1)
Personalized targeted mailing increases mammograms among long-term noncompliant Medicare beneficiaries: a randomized trial (2020) (1)
ASSOCIATION BETWEEN PAYMENT REFORM AND PROVIDER CONSOLIDATION (2017) (1)
Refining the Framework for Payment Reform ACA Implementation — Monitoring and Tracking September 2016 (2016) (1)
Hospital Survival In Rural Markets: Closures, Mergers, And Profitability. (2023) (0)
Abstract 16196: The Economic Value of Statin Therapy (2011) (0)
Editorial changes. (2017) (0)
Overlap In HMO Physician (2004) (0)
Getting the Most From Payments to Medicare Advantage Health Plans-Thoughts on the Controversy. (2022) (0)
ONE-YEAR, P2Y12 ADHERENCE AFTER DRUG ELUTING STENT PLACEMENT AMONG MEDICARE BENEFICIARIES AND THE IMPACT OF “FIRST P2Y12” CHOICE (2019) (0)
Changes in use of low-value services during the COVID-19 pandemic. (2022) (0)
How Emerging Telehealth Models Challenge Policymaking. (2022) (0)
The merits of administrative benchmarks for population-based payment programs. (2021) (0)
Transitioning Our Healthcare System Toward Accountable Care (2015) (0)
The costs of medical technology. (1997) (0)
Achieving value in healthcare. (2005) (0)
Effects of Provider Payment Reform (2016) (0)
Disability and Health Care Expenditures among Medicare Beneficiaries (2019) (0)
Provider behavior and treatment intensification in diabetes care. (2015) (0)
Spending By 5 Percent Enrollment In A Health Plan With A Tiered Provider Network Decreased Medical (2017) (0)
InsurerMarket Structure and Variation in Commercial Health Care Spending (2014) (0)
Informal Caregiving for Diabetes and Diabetic Complications Among Elderly Americans (2001) (0)
Medicare Advantage: Access Costs and Quality (2018) (0)
Reducing Medicare Advantage Benchmarks Will Decrease Plan Generosity, But Those Effects Will Likely Be Modest. (2023) (0)
The Price of Human and Veterinary Formulations of Common Medications-Price Discrimination and Innovation in Prescription Drug Markets. (2022) (0)
The risk of emergency department visits in adults living in rural France (2019) (0)
Spending And Behavior Change: The Authors Reply (2012) (0)
An Enduring SociAl SAfEty nEt Proposal 1 : Transitioning to Bundled Payments in Medicare (2013) (0)
Health care financing systems and the behavior of health care providers (1993) (0)
Who Loses Health Insurance Coverage As Premiums Rise (2006) (0)
Abstract 224: Recent Trends in Coronary Artery Disease Quality Performance and Implications for Clinical Practice in the Era of Alternative Payment Models (2019) (0)
Curbing Health Care Spending: The Provider’s Role (2019) (0)
Health Insurance: Economic and Risk Aspects (2001) (0)
THE COMMONWEALTH FUND 2007-08 HARKNESS FELLOWSHIPS IN HEALTH CARE POLICY AND PRACTICE ORIENTATION SEMINAR PARTICIPANT CONTACT LIST (2007) (0)
Addressing the "chronification" of disease. (2017) (0)
JAMA Internal Medicine Peer Reviewers in 2017. (2018) (0)
Individual Insurance Markets – What Now? (2018) (0)
Slowing medicare spending growth (2012) (0)
Re: Health Care Cost Containment Strategies Used in Four Other High-Income Countries Hold Lessons for the United States (2013) (0)
Taking stock at 2 years--continuing the journey. (2004) (0)
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research (2013) (0)
Clinical and economic analysis of immediate endoscopy, serological screening for H. pylori and empiric treatment of H. pylori for pediatric patients with dyspepsia (1995) (0)
Spending and quality of care for Medicare beneficiaries in Massachusetts--reply. (2013) (0)
Executive Summary : Refining the Framework for Payment Reform ACA Implementation — Monitoring and Tracking (2016) (0)
New Evidence on Public and Private Accountable Care Organizations (2019) (0)
Price Elasticity And Medication Use: Cost-Sharing In Multiple Chronic Conditions (2013) (0)
NHPC Panel: The Path Forward on APMs: What are the Implications of Market Dynamics on APM Adoption? (2020) (0)
Guide for Purchasers: Methodologies for Evaluating Value-Oriented Strategies (2019) (0)
Rapid Fire Session 1B: Opioids and Substance Use Disorders (2018) (0)
Acknowledgment of Reviewers for AJHE during 2015 (2016) (0)
Variation in spending associated with primary care practices. (2020) (0)
The provider culture vis-à-vis new technologies may have greater impact on cost growth than health plans' cost containment strategies. (2004) (0)
Communication and Accountable Care (2015) (0)
After 25 years, AJMC® looks to the future: a Q&A with Michael E. Chernew, PhD, and A. Mark Fendrick, MD. (2020) (0)
Acknowledgment of Reviewers for AJHE during 2016 (2017) (0)
Backstop Price Caps in Commercial Health Care Markets-Reply. (2021) (0)
Hospitalizations But Not Overall Costs A Hospital System ' s Wellness Program Linked To Health Plan Enrollment Cut (2013) (0)
Benefit Design to Promote Effective, Efficient, and Affordable Care: A Vital Direction for Health and Health Care (2016) (0)
Estimating t he C ost o f I nformal C aregiving f or E lderly Patients W ith C ancer (2001) (0)
CN4: THE IMPACT OF THE DIAGNOSIS OF CANCER ON OUT-OF-POCKET HEALTH-CARE EXPENDITURES MADE BY THE US ELDERLY (2001) (0)
Private Sector Strategies to Address High Drug Prices and the Promise of Reference Pricing Programs. (2020) (0)
Benchmarking Changes And Selective Participation In The Medicare Shared Savings Program. (2023) (0)
To Beneficiaries Additional Reductions In Medicare Spending Growth Will Likely Require Shifting Costs (2014) (0)
Value-Based Pricing: The Role of Outcomes Data in Pricing Models (2014) (0)
The 'Graying' Of Group Health (2006) (0)
Quality Contract ' In Massachusetts Medical Group Responses To Global Payment : Early Lessons From The ' Alternative (2011) (0)
Using Consistently Low Performance to Identify Low-Quality Physician Groups (2021) (0)
Perspective The NEW ENGL A ND JOUR NA L of MEDICI NE (2012) (0)
The Children's Cliff — Extending CHIP (2015) (0)
Comparative effectiveness of human papillomavirus vaccination against cervical abnormalities by dose level in a cohort of privately-insured u.s. Girls (2015) (0)
Market Share: The Authors Reply. (2017) (0)
Abstract 35: Trends in Statin Use and Adherence and the Impact of the 2013 Cholesterol Guidelines (2018) (0)
Economic Research Initiative on the Uninsured CONFERENCE DRAFT HOW SIGNIFICANT ARE " MISMATCHES " BETWEEN WORKERS ' PREFEREBCES AND EMPLOYERS ' HEALTH INSURANCE PROVISION IN EXPLAINING AGGREGATE PATTERNS OF COVERAGE ? (2005) (0)
A new chapter in health reform. (2016) (0)
Integrating Patient Incentives with Episode-Based Payment (2013) (0)
Celebrating our 20th anniversary. (2015) (0)
A Sustainable Post-Pandemic Health Care System Needs Adjustable Payment Models (2020) (0)
Tracking Commercial Health Care Spending By Clinical Condition (2016) (0)
Quality and Efﬁciency Does Competition Improve Health Care Quality? (2008) (0)
Let Efficient Providers Prosper (2016) (0)
Correspondence regarding "A benefit-based copay for prescription drugs" [1] (multiple letters) (2002) (0)
Managed Care and Medicare Expenditures (2005) (0)
Tackling Healthcare Costs: Is There Anything New Under the Sun? (2019) (0)
The Inevitable Math behind Entitlement Reform. (2018) (0)
Care Management Within A Pioneer ACO Bending The Spending Curve By Altering Care Delivery Patterns : The Role Of (2017) (0)
A Word From the New Editors (2002) (0)
Commentary on Glied and Sacarny (2018) (0)
VARIATION BY AGE IN THE USE OF NEUROHORMONAL THERAPY IN ISCHEMIC HEART FAILURE WITH REDUCED EJECTION FRACTION (2019) (0)
Impact Of Decreasing Copayments OnMedication AdherenceWithin A Disease Management Environment Value-based cost sharing can increase patients ’ adherence to important medications (2007) (0)
Medicare supplemental coverage: the authors reply. (2013) (0)
Patient Treatment and Procedure Use Insurance Type and Choice of Hospital for Coronary Artery Bypass Graft Surgery (0)
Medicare ACO Program Savings Not Driven by Fewer Hospitalizations for Ambulatory Care-sensitive Conditions or Concentrated among High-risk Patients (2018) (0)
Price Setting for Physician Services-Reply. (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael Esman Chernew?

Michael Esman Chernew is affiliated with the following schools: